[Retrospective study on intervention of traditional Chinese medicine in osteoporosis and related pain diseases]
- PMID: 40686186
- DOI: 10.19540/j.cnki.cjcmm.20250213.702
[Retrospective study on intervention of traditional Chinese medicine in osteoporosis and related pain diseases]
Abstract
Osteoporosis(OP) is a metabolic bone disorder characterized by reduced bone mass and degenerative bone tissue. Osteoporotic pain(OPP) is its most common clinical symptom, significantly affecting the quality of life of patients. With the limitations of modern medical treatments and the intensification of aging, it is imperative to explore more cost-effective interventions for OPP. This paper, based on databases such as China National Knowledge Infrastructure(CNKI), VIP, Wanfang, BioMed, and Web of Science, uncovered the connection between the pathogenesis of OPP in traditional Chinese medicine(TCM) and modern medical mechanisms and retrospectively summarized the basic and clinical research methods and evidence of TCM prescriptions in the treatment of OP and related pain diseases. Studies have shown that TCM prescriptions, focusing on treatments such as nourishing the kidney, strengthening the spleen, and activating blood circulation to remove blood stasis, can significantly improve pain symptoms, increase bone mineral density(BMD), and adjust bone metabolic indicators such as C-terminal telopeptide of type Ⅰ collagen(CTX), serum bone Gla-protein(S-BGP), and alkaline phosphatase(ALP). The mechanisms of action of TCM prescriptions in treating OP and improving OPP symptoms were related to signaling pathways such as Wnt/β-catenin, nuclear factor kappa-B(NF-κB), mitogen-activated protein kinase(MAPK), phosphatidylinositol 3-kinase(PI3K)/protein kinase B(Akt), and the osteoprotegerin(OPG)/receptor activator of NF-κB(RANK)/receptor activator of NF-κB ligand(RANKL) axis. Further strengthening the accumulation and analysis of clinical data, rigorously designing and conducting randomized controlled trials of TCM treatments for OPP with large sample sizes, standardizing outcome measures in basic and clinical research by using methods such as the core outcome set(COS), and incorporating mass spectrometry and omics approaches to uncover more potential active components and mechanisms may contribute to a deeper exploration of the advantages and essence of TCM prescriptions in the treatment of OPP.
Keywords: osteoporosis; osteoporotic pain; pain; prescriptions; traditional Chinese medicine.
Similar articles
-
Meta-analysis of the synergistic effect of traditional Chinese medicine compounds combined with conventional Western medicine in the treatment of osteoporosis.Front Endocrinol (Lausanne). 2025 May 29;16:1606753. doi: 10.3389/fendo.2025.1606753. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40510481 Free PMC article.
-
Oral traditional Chinese medication for adhesive small bowel obstruction.Cochrane Database Syst Rev. 2012 May 16;2012(5):CD008836. doi: 10.1002/14651858.CD008836.pub2. Cochrane Database Syst Rev. 2012. PMID: 22592734 Free PMC article.
-
Research progress of effective components of traditional Chinese medicine in intervening apoptosis of renal tubular epithelial cells in diabetic kidney disease.J Ethnopharmacol. 2025 May 28;348:119874. doi: 10.1016/j.jep.2025.119874. Epub 2025 Apr 23. J Ethnopharmacol. 2025. PMID: 40280372
-
Chinese herbal medicine for oesophageal cancer.Cochrane Database Syst Rev. 2016 Jan 22;2016(1):CD004520. doi: 10.1002/14651858.CD004520.pub7. Cochrane Database Syst Rev. 2016. PMID: 26799001 Free PMC article.
-
Anti-osteoporosis effect of Semen Cuscutae in ovariectomized mice through inhibition of bone resorption by osteoclasts.J Ethnopharmacol. 2022 Mar 1;285:114834. doi: 10.1016/j.jep.2021.114834. Epub 2021 Nov 18. J Ethnopharmacol. 2022. PMID: 34801609
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous